
Human Perilipin-2 63-71, TSALPIIQK
Description
About Human Perilipin-2 63-71, TSALPIIQK
The Human Perilipin-2 Peptide (IEDB: 220300) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Perilipin-2 Peptide, H-TSALPIIQK-OH (Uniprot: Q99541 aa: 63-71) from JPT is produced under strict quality control and quality management.
Human Perilipin-2 63-71, TSALPIIQK - Specifications
- Peptide sequence: H-TSALPIIQK-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Leukemia, Adenocarcinoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Perilipin-2 63-71, TSALPIIQK
References:
Read References with JPT’s Antigen Peptides
Human Perilipin-2 63-71, TSALPIIQK has been described in:
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)., Proc Natl Acad Sci U S A, 2015 (PMID: 25548167)
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient., J Hepatol, 2016 (PMID: 27397612)
Documentation
Documentation for Human Perilipin-2 63-71, TSALPIIQK
Properties
Properties of Human Perilipin-2 63-71, TSALPIIQK
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Adenocarcinoma, Leukemia |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Perilipin-2 |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Perilipin-2 63-71, TSALPIIQK
Information | Values |
---|---|
Sequence: | H-TSALPIIQK-OH |
Specifications: | 9mer peptide as TFA salt |